Aerie Pharmaceuticals


Aerie Pharmaceuticals  Stock Quote
$11.45 -$0.75 -6.1%
Price as of September 21, 2020, 10:39 a.m. EDT View Interactive AERI Charts

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Interactive Chart

News & Analysis: Aerie Pharmaceuticals


Market Moves


Is Aerie Pharmaceuticals a Buy?

Wall Street has given the eye-care specialist the cold shoulder in 2020. Is that an opportunity for individual investors?

Is Aerie Pharmaceuticals a Buy?

The small-cap company's shares have fallen 64% in the last year, but a promising drug portfolio might signal an opportunity for investors with a long-term mindset.